Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

China flag China · Delayed Price · Currency is CNY
22.69
+0.99 (4.56%)
At close: Mar 10, 2026
34.50%
Market Cap 5.81B
Revenue (ttm) 1.39B
Net Income (ttm) 418.37M
Shares Out 256.15M
EPS (ttm) 1.62
PE Ratio 14.01
Forward PE n/a
Dividend 0.35 (1.61%)
Ex-Dividend Date Feb 11, 2026
Volume 9,254,216
Average Volume 3,524,226
Open 22.11
Previous Close 21.70
Day's Range 22.11 - 22.76
52-Week Range 14.90 - 28.77
Beta 0.23
RSI 60.26
Earnings Date Mar 25, 2026

About SHE:002393

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers its products in various forms comprising tablets, capsules, granules, and injections for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigo... [Read more]

Sector Healthcare
Founded 1951
Employees 1,604
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002393
Full Company Profile

Financial Performance

In 2025, SHE:002393's revenue was 1.39 billion, an increase of 4.23% compared to the previous year's 1.34 billion. Earnings were 418.37 million, an increase of 126.72%.

Financial Statements

News

There is no news available yet.